UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Phase 2
Recruiting
- Conditions
- Renal Cell Carcinoma
- Interventions
- Procedure: Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node dissection
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05319015
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
UroLift System With SAbR for Prostate Cancer and BPH
Not Applicable
Active, not recruiting
- Conditions
- Prostate Cancer
- Interventions
- Device: UroliftRadiation: SABR
- First Posted Date
- 2022-04-05
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT05311527
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
Noninvasive Brain Stimulation in Mild Cognitive Impairment and Dementia
Not Applicable
Completed
- Conditions
- Mild Cognitive ImpairmentDementiaAlzheimer Disease
- Interventions
- Device: Active Transcranial direct current stimulation (STARStim 8)Device: Sham Transcranial direct current stimulation (STARStim 8)
- First Posted Date
- 2022-03-08
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT05270408
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care in Texas
Not Applicable
Terminated
- Conditions
- Suicidal Ideation
- Interventions
- Other: STAT-PCOther: YST-III
- First Posted Date
- 2022-03-08
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 3
- Registration Number
- NCT05270785
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)
Phase 2
Recruiting
- Conditions
- Cocaine Use Disorder
- Interventions
- Drug: Extended-Release NaltrexoneDrug: Placebo (PLB) Injectable matched to XR-NTXDrug: Placebo (PLB) Injectable matched to XR-BUP
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 426
- Registration Number
- NCT05262270
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸UCLA Vine Street Clinic, Los Angeles, California, United States
Remote Methadone Ingestion Surveillance Trial (RMIST)
Not Applicable
Completed
- Conditions
- Opioid Use Disorder
- Interventions
- Other: RMIST
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT05259501
- Locations
- 🇺🇸
UNM Addiction and Substance Abuse Program, Albuquerque, New Mexico, United States
Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone Administered Individually or Concurrently
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT05257447
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Nudges on Hospitalist Behavior and Patient Satisfaction
Not Applicable
Completed
- Conditions
- Patient SatisfactionEtiquette, Medical
- Interventions
- Behavioral: Nudge
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 125
- Registration Number
- NCT05250778
- Locations
- 🇺🇸
Parkland Memorial Hospital, Dallas, Texas, United States
Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma
Phase 2
Terminated
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT05249569
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Fractionated 1927nm Laser for Diffuse Pigmentation and Actinic Changes.
Not Applicable
Completed
- Conditions
- Skin Pigment
- Interventions
- Device: MOXI
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05226104
- Locations
- 🇺🇸
UT Southwestern Department of Plastic Surgery, Dallas, Texas, United States